Skip to main content
Download PDF

Socio-economic behavioural indicators of falciparum malaria parasitaemia and moderate to severe anaemia among pregnant women attending antenatal clinics in Lagos, Southwest Nigeria

Malaria Journal volume 19, Article number: 393 (2020) Cite this article

Abstract

Background

Incidence of malaria and anaemia are of public health importance especially in pregnant women in endemic regions, due to the negative health consequences to the mother and fetus. This study aimed to assess the pattern of falciparum malaria infection and anaemia, based on malaria prevention methods practiced by participants.

Methods

A semi-structured tool was used to capture information on demographic, socio-economic and malaria prevention practices from 113 pregnant women attending antenatal clinics in 2 peri-urban health facilities in Lagos, southwest Nigeria. Malaria microscopy was conducted and haematocrit was measured. Logistic regression analysis was performed on the data collated from the survey.

Results

The prevalence of anaemia among pregnant women was 87.2%. The mean (± sd) packed cell volume (PCV) (%) of the 22 (19.5%) infected subjects (26.8 ± 6.6), was significantly lower (t = −2.60, P value = 0.007) than that of the 91 (80.5%) uninfected subjects (30.8 ± 6.0). The prevalence of infection was highest in the 3rd trimester (n = 40, 35.4%) at 27.5% (11/40) and among those in their first pregnancy (n = 32, 28.3%) at 25.0% (8/32). There was a significant difference (t = −2.23, P-value = 0.01) in the mean PCV % of pregnant women who consumed herbal teas in pregnancy (28.2 ± 5.2) compared to those who did not (30.8 ± 6.6). Regression analysis showed that first pregnancy, anti-malarial use and insecticide-treated nets use the night before study had increased odds of malaria infection in participants (OR = 1.35, P = 0.006, 95% CI 0.52−2.49; OR = 2.3, P = 0.005, 95% CI 0.14−0.41; OR = 1.92, P = 0.001, 95% CI 0.62−5.98) while intermittent preventive treatment (IPT) participation and formal education were strongly and significantly associated with lower risk of parasitaemia (OR = 0.95, P = 0.025, 95% CI 0.41−2.26; OR = 0.44, P = 0.005, 95% CI 0.34−10.50).

Conclusion

Interventions that will reduce malaria and moderate to severe anaemia, especially in a first pregnancy, should include education on the correct use of long-lasting insecticide-treated bed nets (LLIN), IPT and the dangers of herbal teas in pregnancy.

Background

Pregnant women are one of the vulnerable groups especially susceptible to malaria because of the sub-optimal immune status conferred by increased steroid levels in pregnancy [1]. Mosquitoes are more attracted to pregnant women and parasitized erythrocytes are sequestered in the placenta by adhesion to the chondroitin sulfate A expressed in the placenta [2] of pregnant women. In areas of stable transmission, it is estimated that malaria during pregnancy causes up to 10,000 maternal deaths each year, mainly as a result of severe anaemia, and accounts for approximately 8–14% of low birth weight (LBW), and 3–8% of infant mortality [3]. Infectious diseases, including malaria, iron and other micronutrient deficiencies, are contributing factors to this pervasive global situation of anaemia, the commonest medical condition in pregnancy which has a global prevalence of 41.8% and rises to as high as 75% in The Gambia [4]. Anaemia prevalence in Nigeria is 58% from recent reports, making it a continuing severe situation [4, 5]. Anaemia is the major contributory or sole cause in 20–40% of maternal deaths [6]. Mechanisms of anaemia causing malaria include lysis of infected and uninfected red blood cells (RBCs), splenic sequestration of RBCs, dyserythropoietic, and bone marrow suppression [7].

Control measures target to be protective of this section of the population in endemic countries to avoid many of the associated complications to the outcome of pregnancy [8]. The use of long-lasting insecticide-treated nets (LLINs), intermittent preventive treatment (IPT) with sulfadoxine-pyrimethamine (SP) and prompt treatment of confirmed malaria are the core strategies for control of malaria in pregnancy in Nigeria [9]. These interventions are delivered in health facilities with an emphasis on the promotion of focused antenatal care [10, 11].

The percentage of women that attend antenatal care (ANC) in health facilities is generally low at 58% across the country, with the lowest rates of ANC attendance observed in the northern states. All pregnant women are to receive at least 3 doses of SP treatments during their ANC visits under directly observed therapy (DOT) and its implementation appears to be fairly well integrated at primary health facility level across the country. LLIN utilization for pregnant women improved from 5% in 2008 to 10% in 2010 and 49% in 2015 [12]. Similarly, the percentage of pregnant women that received at least 2 doses of IPT improved from 6.5% in 2008 [13] to 13.2% in 2010 [14] and 37% in 2015 [15]. Rational use of anti-malarials to treat malaria in pregnancy is well outlined in the Federal Ministry of Health’s National Guidelines for diagnosis and treatment of malaria but deterrents of access to treatment make it difficult to put guidelines into use. Several other practices and factors have been implicated to contribute to malaria infection and anaemia status, including state of education, use of unrecommended herbal medication and the physiological status of the individual concerned. The prevailing factors and practices that predispose to malaria and anaemia in pregnancy are the subject of this study. This study has assessed the prevalence of malaria parasites, moderate to severe anaemia, and factors associated with their risk to pregnant women attending antenatal clinics in two General Hospitals in Ikorodu local government area of Lagos State in Nigeria, to guide intervention with malaria control measures.

Methods

A detailed description of the study population, sample size determination and ethical considerations have been published in an earlier paper [16]. Briefly, a cross-sectional survey was undertaken amongst the study population comprising pregnant women attending antenatal clinic at Ijede General Hospital, Ijede (N06° 34.076 E003° 35.637′) and Ikorodu General Hospital both in Ikorodu Local Government Area (LGA), Lagos State in the period January to April 2009. The inclusion criteria were women with fever or history of fever in 24–48 h preceding presentation at the hospital and those that signed or thumb-printed the consent form. Patients with signs of severe malaria were excluded from the study.

Ethical issues

Ethical approval was obtained from the Nigerian Institute of Medical Research Institutional Review Board. All work was performed according to the guidelines for human experimentation in clinical research and the Helsinki declaration.

Data and sample collection

Structured questionnaires were administered to each pregnant woman designed to collect demographic data, history of drug use, participation in IPT, LLIN possession, information on gestational age, history of obstetrics, and history of febrile illness. Venous (0.5 ml) blood sample was collected from a peripheral vein in each participant by a trained laboratory scientist or technician into a microtainer labelled EDTA bottles. Haematocrit tubes were three-quarters filled and spun at 12,000—15,000×g for 5 min on a haematocrit centrifuge (Hawksley, England). Packed cell volume (PCV) percentage was read of the Haematocrit Reader (Hawksley, England).

To prepare thick and thin blood films, 3 drops of blood were spread in a circle of about 1-cm diameter at one end of the slide, and about 1 cm from that, one drop of blood for the thin film was spotted and spread in a thin film. The films were allowed to dry for about 15 min before fixing the thin film with methanol. The slides were allowed to air dry until the next day. Slides were then stained with 3% Giemsa for 45 min, rinsed, dried, and examined under the microscope as detailed in a previous publication [17]. The results are reported as the number of parasites per high-powered field (HPF) or the number of parasites per 200 HPF. The parasite density per µl is calculated by multiplying the number per HPF by 500, based on assumptions that 5–8 µl of blood is used in making a thick blood film and that 0.002 µl of blood is in an HPF, i.e. 10 X eyepiece, 100 X objective [18].

Anaemia status of the participants was defined using the World Health Organization (WHO) haematocrit cut-off for mild, moderate and severe anaemia based on age and gender. The demographic information of the participants was also recorded.

Data analysis

Inferential and descriptive statistics were used for data presentation. Data entered into Microsoft Excel 2010 were imported into SPSS 20.0 for Windows for analysis. Variables considered in the analysis were related to the presence and densities of malaria parasites, fever, anaemia, and participants’ demographics. Anaemia was classified as mild (PCV 24.0– < 32.0%) or moderate (PCV 18.0- < 24.0%) or severe (PCV < 18.0%). Proportions were compared by calculating Chi square, Fisher’s exact or Mantel–Haenszel tests as appropriate. Normally distributed continuous data were compared by t-test and analysis of variance. Data not conforming to a normal distribution were compared by the Mann–Whitney U tests and the Kruskal–Wallis tests (or by Wilcoxon ranked sum test). P values less than 0.05 were considered statistically significant. Unadjusted and adjusted odds ratios with 95% confidence intervals (CIs) for the associations between exposures and moderate to severe anaemia were computed using logistic regression methods.

Results

Participants’ profile and preventive behavioural characteristics of the study population

Detailed descriptions of the socio-clinical profiles of 113 pregnant women, whose mean (± sd) age was 30.0 years (4.7) are as described in Table 1. Of these 113 pregnant women, 4 (3.6%) were aged < 20 years. Only 5 (4.4%) had no formal education whereas 51 (45.1%) had a minimum of secondary education. Fifty-four (47.8%) were traders, 17 (15.0%) were students and 11 (9.7%) were housewives. In all, 32 (28.3%), 32 (28.3%) and 49 (34.4) were primigravida, secundigravida and multigravida, respectively, while 19 (16.8%), 54 (47.8%) and 40 (35.4%) were in their first, second and third trimester, respectively. Those that had moderate to severe anaemia were 80 (70.8%) contrasting with 33 (29.2%) that presented with no or mild anaemia. Of all the study subjects, only 22 (19.5%) were infected with falciparum malaria parasites among whom 9 (40.9%) were aged 26–30 years, 12 (54.5%) with secondary education, 12 (54.5%) who were traders, 11 (50.0%) in their third trimester, and 10 (45.4%) who were multigravida. A total of 19 (86.4%) of those infected with falciparum malaria parasites (FMP) also had moderate to severe anaemia. Those aged 26-30 years were 1.64 more likely to be infected (χ2 = 1.02, P-value = 0.31, OR = 1.64, 95% CI 0.63, 4.28) than all other ages and pregnant women without formal education were 2.9 times more likely to be infected than others with education (χ2 = 0.37, P-value = 0.54, OR = 2.90, 95% CI 0.46, 18.73). Those in their third pregnancy were 1.60 times more likely to be infected with FMP compared to women of other gravidities (χ2 = 0.86, P-value = 0.35, OR = 1.60, 95% CI 0.60, 4.28) while those in the first trimester were 2.14 times likely to be infected with FMP than those in other trimesters (χ2 = 2.52, P-value = 0.11, OR = 2.14, 95% CI 0.83, 5.50) (Table 1). Those with moderate to severe malaria were 3.1 times likely to be infected than those with mild or no anaemia (χ2 = 2.33, P-value = 0.13, OR = 3.1, 95% CI 0.85, 11.36) (Table 1).

Table 1 Distribution of social and clinical profile of infected and non-infected pregnant women participants attending Ikordu and Ijede General Hospital, Lagos State
Full size table

The frequency of treatment and preventive measures practiced by participants as displayed in Fig. 1 shows that drug treatment was the most commonly practiced malaria control measure. More than 55% of participants had used anti-malarial drugs of one type or another including, artemisinin combination therapy (ACT) (51%), chloroquine or SP (38%) and other anti-malarial medications (38%).

Fig. 1
figure 1

Treatment and prevention measures practiced amongst pregnant women participants attending Ikordu and Ijede General Hospitals in Lagos, Nigeria

Full size image

Association of prevention method, parity and age group presence or non-presence, with peripheral parasitaemia during pregnancy in a univariate and multivariate analysis is presented in Table 2. In the univariate analysis, women in their first pregnancy were 1.35 times more likely to have parasites compared to those in their second or more pregnancy (P-value = 0.006, 95% CI 0.52–2.49). Women under age 20 years were 1.30 times more likely to have parasites compared to women over 20 years old (P-value = 0.05, 95% CI 0.14–12.20). LLIN use was 1.92 times more likely to confer parasitaemia than non-use (P = 0.001, 95% CI 0.62–5.98) and anti-malaria use in pregnancy, 2.3 times more likely to have malaria parasite than women that did not take anti-malaria (P-value, 0.005, 95% CI 0.14–0.41). On the other hand, IPT participation, formal education and herb use conferred a reduced risk of malaria infection compared to non-IPT participation, non-educated, and no herb use, respectively. The odds ratio values in the multivariate analysis follow the same trend as that in the univariate analysis (Table 2).

Table 2 Factors associated with peripheral parasitemia during malaria in pregnancy using univariate and multivariate analysis
Full size table

Figures 2, 3 and 4 are a graphical representation of malaria prevalence and parasitaemia-geometric mean parasite density (GMPD) relative to gravidity, gestational ages and age groups of participants, respectively. Prevalence was highest in the primigravida group while GMPD was highest amongst the secundigravida (Fig. 2). Prevalence was highest amongst the third-trimester pregnancies, while GMPD was highest in the second trimester (Fig. 3). Prevalence was at an equally high rate of 25% in the age groups ≤ 20 years, 21–25 years and 26–30 years with the highest GMPD recording in age group 21–25 years.

Fig. 2
figure 2

Malaria prevalence and parasitaemia (GMPD) according to the gravidity of pregnant women participants attending Ikordu and Ijede General Hospitals in Lagos, Nigeria

Full size image
Fig. 3
figure 3

Malaria prevalence and geometric mean parasite density (GMPD) according to gestational ages of pregnant participants attending Ikordu and Ijede General Hospitals, in Lagos, Nigeria

Full size image
Fig. 4
figure 4

Malaria prevalence and geometric mean parasite density (GMPD) according to age groups of pregnant women participants attending Ikordu and Ijede General Hospitals, in Lagos, Nigeria

Full size image

Anaemia prevalence and risk factors

The prevalence of anaemia among pregnant women in the study was 81.4%. The mean (± sd) as seen in Table 2, PCV of parasitized pregnant women (30.01 ± 4.78) was significantly lower (χ2 = 65.34; P-value = 0.003) than that of non-parasitized pregnant women (30.9 ± 4.81). Further, pregnant women with malaria parasitaemia were 3.1 times more likely to present with moderate-to-severe anaemia compared to non-parasitized pregnant women (χ2 = 2.2; P-value = 0.13; OR: 3.1; 95% CI 0.85–0.11.36: RR:1.29; CI 1.03–1.60). Pregnant women with only primary education were about 6 times more likely to have moderate to severe anaemia compared to those with higher educational standards (χ2 = 2.2; P-value = 0.14; OR: 5.65; 95% CI 0.70, 45.33; RR:1.36; CI 1.10–1.67). Those in the first trimester of pregnancy were 1.19 times likely to present with moderate-to-severe anaemia than those in other trimesters 1.19 (χ2 = 0.09; P-value = 0.76; OR: 1.19; 95% CI 0.39–3.6; RR:1.05; CI 0.78–1.42). Pregnant women in the age group of 26–30 years were 2.7 times more likely to have moderate to severe anaemia compared to other age groups (χ2 = 4.02; P-value = 0.04; OR: 2.70; 95% CI 1.0–7.29; RR:1.28; CI 1.03–1.60). Interestingly, those who consumed medicinal herbs in pregnancy were approximately 1.8 times more likely to present with moderate to severe anaemia than women who did not consume medicinal herbs (χ2 = 1.44, P = 0.23, OR: 1.79; 95% CI 0.69–4.66; RR:1.17, 95% CI 0.92–1.47). However, participants in their first pregnancies, those who slept under LLIN the night before, those that had used anti-malaria in pregnancy and those that participated in IPT, were all less likely to have moderate to severe anaemia compared to those who had had more than one pregnancy, those that did not sleep under LLIN, those that had used anti-malaria and participated in IPT, respectively (Table 3).

Table 3 Behavioural factors associated with anaemia during malaria in pregnancy using univariate
Full size table

Discussion

Earlier reports on the prevalence of anaemia in malaria and diagnostic performance of malaria detection methods compared with microscopy are auxiliary to this study [19, 20]. This study determined the association of prevention methods, socio-economic factors and some clinical criteria in pregnancy with the presence of malaria parasite and moderate to severe anaemia amongst the participants in this report.

Investigation revealed a low prevalence of malaria infection but a high prevalence of anaemia among pregnant women attending ANC in Lagos, South West Nigeria. The coverage of LLINs and IPT use during pregnancy was low. IPT use and education were well related to reduced prevalence of malaria and moderate to severe anaemia; mothers pregnant for the first time, those that had used anti-malarials or herbs during pregnancy were more likely to have falciparum parasitaemia.

In a similar study in Lagos, young maternal age (< 20 years) and primigravida had the same trend of association of increased risk of malaria infection as in this study. Maternal age (< 20 years) was however significantly associated with increased risk of malaria infection in that study, while primigravida was significantly associated with the same in this study. The present study similarly agreed with LLIN use not being associated with a reduction in malaria infection among study participants. Contrarily, however, low educational level was not associated with infection in that study as it is in this study [21].

In another study from the north of Nigeria, a similar association of higher odds was found with primigravida and a lack of education but unlike this current study, non-usage of LLINs was listed as increasing the odds of being infected with malaria [22]. LLINs are associated with reduced risk of malaria infection in several studies [22,23,24,25], although, others aligned with non-association or even significantly higher presence of parasitaemia with use, as observed in this study [26,27,28]. It has been suggested that the contrary to the expected association of higher prevalence with LLIN use observed in this study may be due to low ownership of LLINs in the communities lived in by participants. The community coverage of LLINs in the study may have been inadequate to confer a collective protective effect. LLIN use in the present study population study was low at 15% and the study was at a time when the national utilization of LLINs was 10% [15]. Furthermore, evidence suggests that ‘possession’ and ‘sleeping under LLIN the night before’ may not be satisfactory indicators to register protection by LLINs. Indicators of physical integrity and bio-efficacy, including good use, good physical integrity and biological efficacy of LLINs, have been shown to contribute to LLIN efficacy against malaria infection in the first trimester of the pregnant women studied [29]. Future investigations should seek to capture information on the age of LLINs, the number and size of holes in them (proportionate hole index (PHI)), their appropriate use, as factors in the measure of LLIN efficacy [30].

Education is an important predictor of how positive health status of individuals and extent of education in a population confers advantages in public health [31]. In this current study, the odds of having malaria infection was less amongst the educated compared to non-educated. In the case of anaemia, the odds of having moderate to severe anaemia amongst pregnant women with only a primary school education was 5.6 times compared to women of other educational qualification. That education confers knowledge is evidenced in a reported knowledge attitude and practice (KAP) study attributing knowledge of cause and symptoms of malaria to reduced infection rates among educated respondents compared to non-educated counterparts [23]. Other studies that have shown a positive association of a higher level of education with reduced odds of infection with malaria parasite abound in the literature [7, 32]. Anti-malarial use was 2.3 times more significantly likely to have malaria parasite than non-use in this study, as witnessed in an urban Colombian study where individuals receiving anti-malarial treatment in the previous month had around twice the risk of being infected as compared with those without treatment [33] A similar phenomenon was recorded in a Ghanaian community where the odds of malaria infection among those who received anti-malarial drugs 1 week before was 4.03 times more than in those who did not receive anti-malarials [34]. Over-prescription, over-diagnosis and self-medication are concurrent challenges known to contribute to chronic malaria infection [35, 36].

Anaemia was highly prevalent amongst the pregnant women surveyed in this study as reported [20]. Women who had malaria infection, those with only primary education and women who used herbs during pregnancy, had a higher odds of moderate to severe anaemia compared to other pregnant women in this study. On the other hand, the odds for women that used LLIN the night before and those that participated in IPT in pregnancy; to have moderate to severe anaemia were less than those that did not. The high burden of severe anaemia in pregnancy seen in this study is a well-established association with non-use of LLIN and IPTp in endemic regions [5, 37, 38]. Urban residence, some level of education and upper wealth quantile had reduced odds of moderate to severe anaemia in a Tanzanian study of women of reproductive age and showed some similarity with this study [39]. A traditional home birth study in Benin City, Nigeria, observed that malaria and the use of herbal remedies individually increased the odds of anaemia in pregnancy comparable to this study [40] and a Burkina Faso study of asymptomatic malaria cases that correlated with anaemia in pregnant women corroborated the same observation. The prevalence of anaemia at 71% was lower than in this study compared to the Benin study, perhaps because participants were asymptomatic compared to symptomatic participants recruited in the present study [41]. Malaria infection not only causes clearance of opsonized, intact, infected RBCs and ruptured cells after completion of the parasite’s intra-erythrocytic life cycle, but also clearance of uninfected cells. It is estimated that 10 uninfected cells are cleared from circulation for every infected cell, making it a crucial mechanism for the development of malarial anemia [42]. LLIN use the night before did not confer reduced risk to anaemia in observations from the Tanzanian demographic health survey contrary to observations in this study where protection was conferred against moderate to severe anaemia. That LLIN use conferred protection from moderate to severe anaemia but not from parasite infection herein may imply that LLINs nevertheless played a role in preventing malaria infection that has gone undetectable and which would have yet resulted in anaemia in this study [39]. IPT use in pregnancy has been associated with improved anaemia status in this and several other studies in Uganda [43], Ghana [44,45,46] and other countries [47], while administration of IPT was inconsequential in the development of maternal anaemia in other studies [48]. Herbal remedy users were 33% in this study similar to one-third rate observed in an Ibadan study of determinants of self-medication practices among pregnant women [49], but less than 67.5% in a study covering three geopolitical regions in Nigeria [50] and 68% seen in Abeokuta [51]. Association of herbal remedy use as a risk factor of moderate to severe anaemia is not well covered in literature and offers the opportunity to answer a cause/effect question considering the high prevalence of both the practice and condition in Nigeria. It is rational to infer that sub-therapeutic anti-malarial activities of herb teas results in chronic malaria which would likely result in anaemia. As was observed in the association of status of education with malaria infection, poor or no education is seen to increase the odds of moderate to severe anaemia in this study. Similar results associating education of women with less odds of having moderate to severe anaemia was also reported by other studies in Tanzania [39, 52, 53].

Conclusion

Increased awareness of cause, symptoms and prevention of malaria and moderate to severe anaemia is necessary to protect pregnant mothers in the populace. Investigative research should be conducted to enquire into the proper utilization and physical integrity of LLINs in circulation amongst pregnant women, while intervention that will ensure rational anti-malarial drug use and discourage herbal medication in pregnancy should be implemented.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

OR:

Odds ratio

CI:

Confidence interval

IPTp:

Intermittent preventive treatment in pregnancy

SD:

Standard deviation

SP:

Sulfadoxine-pyrimethamine

DOT:

Directly observed therapy

ANC:

Antenatal care

LLINs:

Long-lasting insecticide nets

RBC:

Red blood cells

LBW:

Low birth weight

IPT:

Intermittent preventive treatment

SP:

Sulfadoxine-pyrimethamine

HPF:

High powered field

PCV:

Packed cell volume

EDTA:

Ethylenediaminetetraacetic acid

FMP:

Falciparum malaria parasite

GMPD:

Geometric mean parasite density

ACT:

Artemisinin-based combination therapy

References

  1. Bouyou-Akotet MK, Adegnika AA, Agnandji ST, Ngou-Milama E, Kombila M, Kremsner PG, et al. Cortisol and susceptibility to malaria during pregnancy. Microbes Infect. 2005;7:1217–23.

    Article  CAS  PubMed  Google Scholar 

  2. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science. 1996;272:1502–4.

    Article  CAS  PubMed  Google Scholar 

  3. Parise M, Nahlen B, Menendez C, Steketee R, Nahlen B, Parise M, et al. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001 1;64(1_suppl):28–35.

  4. WHO, CDC. Worldwide Prevalence of Anemia 1993–2005 WHO Global Database on Anemia. 2008 http://apps.who.int/iris/bitstream/10665/43894/1/9789241596657_eng.pdf.

  5. WHO. The global prevalence of anaemia in 2011. Geneva; World Health Organization, 2015. Available from: http://apps.who.int/iris/bitstream/10665/177094/1/9789241564960_eng.pdf.

  6. Stoltzfus RJ, Dreyfuss ML. Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. International Nutritional Anemia Consultative Group (INACG). Geneva, World Health Organization, 1998. www.who.int/nutrition/publications/micronutrients/guidelines_for_Iron_supplementation.pdf.

  7. Sumbele IUN, Sama SO, Kimbi HK, Taiwe GS. Malaria, moderate to severe anaemia, and malarial anaemia in children at presentation to hospital in the Mount Cameroon area: a cross-sectional study. Anemia. 2016;2016:1–12.

    Article  Google Scholar 

  8. Marchesini P, Crawley J. Reducing the burden of malaria in pregnancy. Roll Back Malaria, Geneva, World Health Organization, 2004. https://www.who.int/malaria/publications/atoz/merajan2003.pdf?ua=1.

  9. Federal Ministry of Health. National Malaria Strategic Plan 2014-2020. 2014.

  10. WHO. Malaria in pregnant women. Geneva, World Health Organization, 2017. https://www.who.int/malaria/areas/high_risk_groups/pregnancy/en/.

  11. Tunçalp Ӧ, Pena-Rosas J, Lawrie T, Bucagu M, Oladapo O, Portela A, et al. WHO recommendations on antenatal care for a positive pregnancy experience-going beyond survival. BJOG. 2017;124:860–2.

    Article  PubMed  Google Scholar 

  12. National Malaria Elimination Programme, ICF International. Nigeria Malaria Indicator Survey 2015: Key Indicators. 2016; https://dhsprogram.com/pubs/pdf/MIS20/MIS20.pdf.

  13. Federal Ministry of Health. Nigeria Demographic and Health Survey. 2008.

  14. National Malaria Elimination Programme, ICF International. Nigeria Malaria Indicator Survey. 2012. https://dhsprogram.com/pubs/pdf/MIS8/MIS8.pdf.

  15. Federal Ministry of Health. National Malaria Indicator Survey. 2015.

  16. Olukosi A, Agomo C, Aina O, Akindele S, Okoh H, Brai B, et al. Prevalence of malaria and anaemia during the dry season in northcentral and southwestern Nigeria. J Parasitol Vector Biol. 2018;10:8–18.

    Google Scholar 

  17. Kolawole OM, Mokuolu OA, Olukosi YA, Oloyede TO. Population genomics diversity of Plasmodium falciparum in malaria patients attending Okelele Health Centre, Okelele, Ilorin, Kwara State Nigeria. Afr Health Sci. 2016;16:704–11.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Molineaux L, Gramiccia G. The Garki Report: Research on the epidemiology and control of malaria in the Sudan Savanna of West Africa. Geneva, World Health Organization. 1980. https://apps.who.int/iris/bitstream/handle/10665/40316/9241560614.pdf?sequence=1&isAllowed=y.

  19. Olukosi A, Sowemimo O, Ajibaye S, Orok B, Aina O, Amure O, et al. Performance of microscopy method and rapid diagnostic tests in malaria diagnosis amongst pregnant women in Lagos Southwest Nigeria. Divers Equal Health Care. 2018;15:104–9.

    Google Scholar 

  20. Olukosi A, Afolabi B. Malaria and anemia among pregnant women living in communities along the coast of Lagos Lagoon, South-west Nigeria. Int J Pregnancy Child Birth. 2018;4:175–82.

    Google Scholar 

  21. Agomo CO, Oyibo WA. Factors associated with risk of malaria infection among pregnant women in Lagos Nigeria. Infect Dis Poverty. 2013;2:19.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Fana SA, Bunza MDA, Anka SA, Imam AU, Nataala SU, Sani F, et al. Prevalence and risk factors associated with malaria infection among pregnant women in a semi-urban community of north-western Nigeria. Infect Dis Poverty. 2015;24(4):24.

    Article  Google Scholar 

  23. Dawaki S, Al-Mekhlafi HM, Ithoi I, Ibrahim J, Atroosh WM, Abdulsalam AM, et al. Is Nigeria winning the battle against malaria? Prevalence, risk factors and KAP assessment among Hausa communities in Kano State. Malar J. 2016;8(15):351.

    Article  Google Scholar 

  24. Ochomo E, Chahilu M, Cook, Jackie Kinyari T, Bayoh N, West P, Kamau L, et al. Insecticide-Treated nets and protection against insecticide-resistant malaria vectors in Western Kenya. Emerg Infect Dis. 2017; 23:758–64.

  25. Fokam EB, Dzi KTJ, Ngimuh L, Enyong P. The effect of long lasting insecticide bed net use on malaria prevalence in the Tombel Health District South West Region-Cameroon. Malar Res Treat. 2016;2016:3216017.

    PubMed  PubMed Central  Google Scholar 

  26. Onyiah A, Ajayi I, Dada-Adegbola H, Adedokun B, Balogun M, Nguku P, et al. Long-lasting insecticidal net use and asymptomatic malaria parasitaemia among household members of laboratory-confirm ed malaria patients attending selected health facilities in Abuja, Nigeria, 2016: a cross- sectional survey. PLoS ONE. 2018;13:e0203686.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Ouattara AF, Dagnogo M, Olliaro PL, Raso G, Tanner M, Utzinger J, et al. Plasmodium falciparum infection and clinical indicators in relation to net coverage in central Côte d’Ivoire. Parasit Vectors. 2014;7:306.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Koram KA, Bennett S, Adiamah JH, Greenwood BM. Socio-economic risk factors for malaria in a peri-urban area of The Gambia. Trans R Soc Trop Med Hyg. 1995;89:146–50.

    Article  CAS  PubMed  Google Scholar 

  29. Hounkonnou C, Djènontin A, Egbinola S, Houngbegnon P, Bouraima A, Soares C, et al. Impact of the use and efficacy of long lasting insecticidal net on malaria infection during the first trimester of pregnancy - a pre-conceptional cohort study in southern Benin. BMC Public Health. 2018;18:683.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Boussougou-Sambe ST, Awono-Ambene P, Tasse GCT, Etang J, Binyang JA, Nouage LD, et al. Physical integrity and residual bio-efficacy of used LLINs in three cities of the South-West region of Cameroon 4 years after the first national mass-distribution campaign. Malar J. 2017;16:31.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Zimmerman EB, Woolf SH, Haley A. Understanding the relationship between education and health: a review of the evidence and an examination of community perspectives. In: Kaplan R, Spittel M, David D, Eds. Population Health: Behavioral and Social Science Insights. Rockville: Agency for Healthcare Research and Quality and Office of Behavioral and Social Sciences Research, National Institutes of Health; 2015. p. 251–67.

  32. Oliveira MAA, Osório MM, Raposo MCF. Socioeconomic and dietary risk factors for anemia in children aged 6 to 59 months. J Pediatr (Rio J). 83:39–46.

  33. Mendez F, Carrasquilla G, Muñoz A. Risk factors associated with malaria infection in an urban setting. Trans R Soc Trop Med Hyg. 2000;94:367–71.

    Article  CAS  PubMed  Google Scholar 

  34. Kweku M, Takramah W, Takase M, Tarkang E, Adjuik M. Factors associated with malaria prevalence among children under five years in the Hohoe Municipality of Ghana. J Transm Dis Immun. 2017;1:1–10.

    Google Scholar 

  35. Altaras R, Nuwa A, Agaba B, Streat E, Tibenderana JK, Strachan CE. Why do health workers give anti-malarials to patients with negative rapid test results? A qualitative study at rural health facilities in western Uganda. Malar J. 2016;15:23.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Chipwaza B, Mugasa JP, Mayumana I, Amuri M, Makungu C, Gwakisa PS. Self-medication with anti-malarials is a common practice in rural communities of Kilosa district in Tanzania despite the reported decline of malaria. Malar J. 2014;13:252.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Mohammad S, Shayan S, Shweta, Kumari Aakanksha B, Faisal Z, Shadab A, et al. Prevalence of malaria infection and risk factors associated with anaemia among pregnant women in semiurban community of Hazaribag, Jharkhand, India. Biomed Res Int. 2015;2015:16.

  38. Corrêa G, Das M, Kovelamudi R, Jaladi N, Pignon C, Vysyaraju K, et al. High burden of malaria and anemia among tribal pregnant women in a chronic conflict corridor in India. Confl Health. 2017;11:10.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wilunda C, Massawe S, Jackson C. Determinants of moderate-to-severe anaemia among women of reproductive age in Tanzania: analysis of data from the 2010 Tanzania Demographic and Health Survey. Trop Med Int Health. 2013;18:1488–97.

    Article  PubMed  Google Scholar 

  40. Oladehinde B, Omoregie R, Odia I, Oladeinde O. Prevalence of malaria and anaemia among pregnant women attending a traditional birth home in Benin City Nigeria. Oman Med J. 2012;27:232–6.

    Article  Google Scholar 

  41. Douamba Z, Bisseye C, Djigma F, Tegwinde, Compaoré Valérie B, Pietra V, Nikiema J-B, et al. Asymptomatic malaria correlates with anaemia in pregnant women at Ouagadougou, Burkina Faso. J Biomed Biotechnol. 2012;2012;198317.

  42. Kai OK, Roberts DJ. The pathophysiology of malarial anaemia: where have all the red cells gone? BMC Med. 2008;6:24.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Ononge S, Campbell O, Mirembe F. Haemoglobin status and predictors of anaemia among pregnant women in Mpigi Uganda. BMC Res Notes. 2014;7:712.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Orish VN, Onyeabor OS, Boampong JN, Afoakwah R, Nwaefuna E, Acquah S, et al. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana. Afr Health Sci. 2015;15:1087–96.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Owusu-Boateng I, Anto F. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana. Malar J. 2017;16:323.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Wilson NO, Ceesay FK, Obed SA, Adjei AA, Gyasi RK, Rodney P, et al. Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women. Am J Trop Med Hyg. 2011;85:12–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Manirakiza A, Serdouma E, Ngbalé RN, Moussa S, Gondjé S, Degana RM, et al. A brief review on features of falciparum malaria during pregnancy. J Public Health Africa. 2017;31(8):668.

    Google Scholar 

  48. Mathanga DP, Uthman OA, Chinkhumba J. Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women. Cochrane database Syst Rev. 2011; 5;:CD006689.

  49. Yusuff KB, Omarusehe L-D. Determinants of self medication practices among pregnant women in Ibadan Nigeria. Int J Clin Pharm. 2011;1(33):868–75.

    Article  Google Scholar 

  50. Fakeye TO, Adisa R, Musa IE. Attitude and use of herbal medicines among pregnant women in Nigeria. BMC Complement Altern Med. 2009;31(9):53.

    Article  Google Scholar 

  51. Sam-Wobo S, Akinboroye T, J A, Adewale B. Knowledge and practices on malaria treatment measures among pregnant women in Abeokuta, Nigeria. Tanzan J Health Res. 2008;10:226–31.

  52. Ayoya MA, Bendech MA, Zagré NM, Tchibindat F. Maternal anaemia in West and Central Africa: time for urgent action. Public Health Nutr. 2012;15:916–27.

    Article  PubMed  Google Scholar 

  53. Sanou D, Ngnie-Tet I. Risk factors for anemia in preschool children in sub-Saharan Africa. In: Silverberg D, editor. anemia. Ottawa: InTech; 2012. p. 171–90.

    Google Scholar 

Download references

Acknowledgements

We acknowledge the staff of Ijede General Hospital and Ikorodu General Hospital. We also appreciate the women that participated in this study.

Funding

This study was self-funded. The project was executed in partial fulfillment of obtaining a Master’s thesis in Public health.

Author information

Authors and Affiliations

  1. Nigerian Institute of Medical Research, 6, Edmund Crescent, PMB 2013, Yaba, Lagos, Nigeria

    Adeola Y. Olukosi, Abiodun Olakiigbe, Olusola Ajibaye, Bassey A. Orok, Olugbenga O. Aina, Samuel K. Akindele, Olajumoke O. Akinyele, Samson T. Awolola & Tolulope Arowolo

  2. College of Medicine, University of Lagos, Idi-araba, Lagos, Nigeria

    Olajumoke O. Akinyele, Adebayo T. Onajole & Tolulope Arowolo

  3. Health, Environment and Development Foundation, Surulere, Lagos, Nigeria

    Olajumoke O. Akinyele, Tolulope Arowolo & Bamigboye M. Afolabi

Authors
  1. Adeola Y. Olukosi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abiodun Olakiigbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Olusola Ajibaye
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bassey A. Orok
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Olugbenga O. Aina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Samuel K. Akindele
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Olajumoke O. Akinyele
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Adebayo T. Onajole
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Samson T. Awolola
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Tolulope Arowolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Bamigboye M. Afolabi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AYO and ATO designed the study AO and BMA analysed it, AYO, OA, BAO, OOA, SAK, OOA and TA conducted the fieldwork, AYO and BMA wrote the article and STA and BMA supervised it. All authors read and approved the final manuscript

Corresponding author

Correspondence to Adeola Y. Olukosi.

Ethics declarations

Ethical declaration

Ethical approval was obtained from the Nigerian Institute of Medical Research Institutional Review Board (IRB/08/075). All work was performed according to the guidelines for human experimentation in clinical research and the Helsinki declaration.

Consent for publication

Not applicable.

Competing interests

The authors have declared that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Olukosi, A.Y., Olakiigbe, A., Ajibaye, O. et al. Socio-economic behavioural indicators of falciparum malaria parasitaemia and moderate to severe anaemia among pregnant women attending antenatal clinics in Lagos, Southwest Nigeria. Malar J 19, 393 (2020). https://doi.org/10.1186/s12936-020-03462-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12936-020-03462-8

Keywords

Malaria Journal

ISSN: 1475-2875

Contact us